Overview
No overview information available.
Background
No background information available.
Indication
用于治疗由葡萄球菌属（包括耐甲氧西林金黄色葡萄球菌MRSA）、链球菌属、肠球菌属、摩根菌属、大肠埃希氏菌、普罗威登氏菌属、柠檬酸杆菌属、克雷伯菌属、肠杆菌属、沙雷氏菌属、变形杆菌属、假单孢菌属、消化链球菌属等敏感菌引起的单纯性尿路感染，如膀胱炎、尿道炎等。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Balofloxacin Tablets | 国药准字H20080685 | 化学药品 | 片剂 | 8/23/2023 | |
| Balofloxacin Tablets | 国药准字H20100143 | 化学药品 | 片剂 | 4/8/2020 | |
| Balofloxacin Tablets | 国药准字H20080131 | 化学药品 | 片剂 | 11/21/2022 | |
| Balofloxacin Tablets | 国药准字H20090137 | 化学药品 | 片剂 | 9/28/2023 | |
| Balofloxacin Tablets | 国药准字H20194053 | 化学药品 | 片剂 | 7/3/2019 | |
| Balofloxacin Capsules | 国药准字H20090126 | 化学药品 | 胶囊剂 | 9/28/2023 | |
| Balofloxacin Capsules | 国药准字H20163111 | 化学药品 | 胶囊剂 | 1/29/2021 | |
| Balofloxacin Capsules | 国药准字H20080695 | 化学药品 | 胶囊剂 | 8/23/2023 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||